The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, 1800 Orleans St, Baltimore, MD, 21287, USA,
Curr Urol Rep. 2013 Oct;14(5):488-95. doi: 10.1007/s11934-013-0350-9.
Lymphadenectomy is utilized in both pelvic and retroperitoneal oncological surgery as a means to eradicate locoregional disease, improve staging accuracy and guide adjuvant therapy. However, pelvic and retroperitoneal lymphadenectomy have the potential for morbidity including lymphatic injury, vascular injury, thromboembolic events and neurologic injury. Across the spectrum of urologic malignancies, the evidence supporting both the necessity and the extent of lymphadenectomy varies considerably. Awareness of the potential for injury and ways to avoid and manage the most common complications is necessary to decrease the morbidity associated with these procedures.
淋巴结切除术在盆腔和腹膜后肿瘤外科中被用作消除局部区域疾病、提高分期准确性和指导辅助治疗的手段。然而，盆腔和腹膜后淋巴结切除术有发生并发症的风险，包括淋巴损伤、血管损伤、血栓栓塞事件和神经损伤。在各种泌尿系统恶性肿瘤中，支持淋巴结切除术的必要性和范围的证据差异很大。了解损伤的可能性以及避免和处理最常见并发症的方法对于降低这些手术相关的发病率是必要的。
